OliX Pharm: Capital Raise of 111 Billion Won from Investors Including L'Oreal's Venture Fund
OliX Pharmaceuticals announced that it plans to conduct a capital raise through a third-party allocation worth approximately 111 billion won to raise operating funds, including for research and development.
The investors participating in this capital raise include L’Oréal Group’s venture fund, Weiss Asset Management, and Brookdale International Partners.
Overall, I have a Positive View of this capital raise. OliX is raising a capital of 111 billion won from top-tier investor base including L’Oréal Group’s venture fund.
Source: OliX Pharm
